Aveanna Healthcare Holdings (AVAH) Return on Sales (2020 - 2026)
Aveanna Healthcare Holdings' Return on Sales history spans 7 years, with the latest figure at 0.27% for Q1 2026.
- For Q1 2026, Return on Sales rose 21.0% year-over-year to 0.27%; the TTM value through Jan 2026 reached 0.09%, up 10.0%, while the annual FY2026 figure was 0.09%, 10.0% up from the prior year.
- Return on Sales reached 0.27% in Q1 2026 per AVAH's latest filing, up from 0.02% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.27% in Q1 2026 to a low of 1.07% in Q3 2022.
- Average Return on Sales over 5 years is 0.09%, with a median of 0.01% recorded in 2025.
- Peak YoY movement for Return on Sales: crashed -107bps in 2022, then soared 112bps in 2023.
- A 5-year view of Return on Sales shows it stood at 0.53% in 2022, then soared by 90bps to 0.05% in 2023, then soared by 212bps to 0.06% in 2024, then crashed by -61bps to 0.02% in 2025, then surged by 1097bps to 0.27% in 2026.
- Per Business Quant, the three most recent readings for AVAH's Return on Sales are 0.27% (Q1 2026), 0.02% (Q3 2025), and 0.05% (Q2 2025).